06:41:28 EDT Mon 16 Jul 2018
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:CELG - Celgene Corporation - http://www.celgene.com06:41:28 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CELG - Q0.185.05 · 86.700.185.69    147.17  74.13Jul 13 19:59:37Jul 1015 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2018-07-10 07:30U:CELGNews ReleaseAnti-PD-L1 Immunotherapy Plus ABRAXANE ® Significantly Reduced the Risk of Disease Worsening or Death in Patients with Metastatic or Locally Advanced Triple Negative Breast Cancer in Phase III IMpassion130 Study
2018-07-09 16:52U:CELGNews ReleaseCelgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE ’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
2018-07-02 07:30U:CELGNews ReleaseCelgene Corporation to Announce Second Quarter 2018 Results on July 26, 2018
2018-06-28 16:30U:CELGNews ReleaseCelgene and Acceleron Announce Luspatercept Achieved Primary and Key Secondary Endpoints in Phase III ‘MEDALIST ’ Study in Patients with Low-to-Intermediate Risk Myelodysplastic Syndromes
2018-06-19 16:30U:CELGNews ReleaseCelgene Corporation Announces Appointment of Jonathan Biller as Executive Vice President and General Counsel Following the Departure of Gerald F. Masoudi